Niagen Bioscience, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
NAGE$2.28+10.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference · Filed orFurnishedHerewith | ||||||
|---|---|---|---|---|---|---|
| Exhibit No. · Description · Form · File Number · Exhibit · Filing Date | ||||||
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant | 10-K | 001-37752 | 3.1 | 3/15/2018 | |
| 3.2 | Certificate of Amendment to the Certificate of Incorporation | 8-K | 001-37752 | 3.1 | 4/12/2016 | |
| 3.3 | Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation | 8-K | 000-53290 | 3.1 | 3/19/2025 | |
| 3.4 | Amended and Restated Bylaws of Niagen Bioscience, Inc. | 8-K | 000-53290 | 3.1 | 3/19/2025 | |
| 4.1 | Form of Stock Certificate representing shares of the Registrant’s Common Stock | 10-Q | 001-37752 | 4.1 | 5/7/2025 | |
| 10.1 | Niagen Bioscience, Inc. 2017 Equity Incentive Plan, as amended + | 8-K | 001-37752 | 10.1 | 6/27/2025 | |
| 10.2 | Niagen Bioscience, Inc. Employee Stock Purchase Plan + | 8-K | 001-37752 | 10.2 | 6/27/2025 | |
| 10.3 | Sales Agreement, dated July 25, 2025, by and between ChromaDex, Inc. and W. R. Grace & Co.-Conn. * | 8-K | 001-37752 | 10.1 | 7/29/2025 | |
| 31.1 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(A) of the Securities Exchange Act of 1934, as amended | X | ||||
| 31.2 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(A) of the Securities Exchange Act of 1934, as amended | X | ||||
| 32.1 | Certification pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002) | X | ||||
| 101.INS | Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||
| 104 | 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||
| * | Certain portions of this exhibit are omitted because they are both not material and are the type that the Registrant treats as private or confidential. |
|---|---|
| + | Indicates management contract or compensatory plan or arrangement. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.